|
SUBSEQUENT EVENTS
|
9 Months Ended |
|---|---|
|
Jan. 31, 2013
|
|
| Subsequent Events [Abstract] | |
| SUBSEQUENT EVENTS |
SUBSEQUENT EVENTS
The Company has performed an evaluation of subsequent events in accordance with ASC Topic 855, noting no additional subsequent events other than those noted below.
Subsequent to January 31, 2013, the Company granted 1,840,000 shares of common stock for services.
Subsequent to January 31, 2013, the Company and SG Austria mutually agreed to continue and extend the current agreement and its terms through the second quarter of 2013.
Subsequent to January 31, 2013, the Company received $62,500 in conjunction with its Private Placement Memorandum.
On February 11, 2013, Medical Marijuana Sciences, Inc. (“MMS”), was incorporated in the State of Nevada and became a wholly-owned
subsidiary of the Company. MMS will conduct research and development for the treatment of diseases using compounds derived from the plant Cannabis sativa.
|